Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02616341

Enrollment

Registered

2015-11-26

Start date

2012-11-30

Completion date

2016-02-29

Last updated

2017-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder

Brief summary

The overall aim of this study is to determine modifications to Exposure and Response Prevention (ERP) therapy that are needed in order to effectively deliver treatment for Obsessive Compulsive Disorder (OCD) in a community mental health center. This study is the final study in a series of three projects executed to adapt and pilot-test a team ERP (T-ERP) intervention that will optimize therapist time by utilizing paraprofessionals to assist with group-ERP treatment plans. The intervention will be tailored to meet the unique needs of low-SES individuals with OCD and be implemented in a community mental health center (CMHC).

Interventions

BEHAVIORALTeam ERP (T-ERP) Intervention

BEHAVIORALTreatment as Usual (TAU)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

1. 18 Years to 65 Years 2. English speaking 3. Primary DSM-IV OCD (identified by the patient and therapist as the most problematic disorder over the past year) 4. At least moderate severity OCD (YBOCS \> 16) 5. Not currently on psychotropic medications or on the same psychotropic medications for at least 4 weeks prior to screening 6. Have never received 10 or more sessions of ERP 7. Not currently attending psychotherapy for OCD 8. Low-income based on the U.S. Housing and Urban Development (HUDs) threshold for RI (less than $41,000 per year for individuals).

Exclusion criteria

1. Significant cognitive impairment (MMSE \< 25) 2. Prominent suicidal ideation 3. Current psychosis, mania, alcohol or drug dependence as assessed by the SCID-P. 4. Prominent Hoarding

Design outcomes

Primary

Measure	Time frame
Changes in OCD symptom severity as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)	Baseline, 6th week of treatment, 12th week of treatment, 3 months post-treatment, 6 months post-treatment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026